PDS Biotechnology Corp
PDSB· Nasdaq
Released Aug 13, 2026, before the open
10-Q filed Aug 13, 2026, 44 days after period end · 0001140361-26-032824
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$9.75M | -$9.43M | -$8.33M | -$11.53M |
| EPS Diluted | -$0.18 | -$0.21 | -$0.23 | -$0.37 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
PDS Biotechnology Corp · CIK 1472091 · Engraved from SEC EDGAR